awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28082793-79E88838-E667-4C57-9644-B81E22152297
Q28082793-79E88838-E667-4C57-9644-B81E22152297
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082793-79E88838-E667-4C57-9644-B81E22152297
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
P2860
Q28082793-79E88838-E667-4C57-9644-B81E22152297
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082793-79E88838-E667-4C57-9644-B81E22152297
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7190cce64877cfcd971c90b31746b782a001c7b
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.